Neostigmine is water-soluble, an ionized compound that reversibly inhibits the enzyme acetylcholinesterase. Its FDA indication is for the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery. The use of neostigmine is primarily found in the context of the reversal of neuromuscular blockade during the administration of anesthesia to patients undergoing surgery that require muscle relaxation. After administration of neostigmine, the concentration of acetylcholine is increased in the neuromuscular junction which allows for muscles to contract with full strength and patients can breathe spontaneously and protect their airways safely after emergence from anesthesia.
You will receive academic credit for your work as it will be published and indexed in PubMed.
Write a brief review article summary and write 1-3 questions with explanations on the topic you select.
You will receive academic credit for your work as it will be published and indexed in PubMed.
Edit and sometimes help write a brief review article summary (1000 words); edit/improve/peer review questions already written on the topic; and possibly write a few new questions on the topic if needed.
Editors-in-Chief receive a 5% annual royalty for managing the publication of content developed within your specialty.
Manipulate the database of questions and review articles assigned to your specialty area; suggest new keyword articles that should be added; and assist in recruiting authors and editors.
